Macrogenics Inc (MGNX)
4.08
-0.16
(-3.77%)
USD |
NASDAQ |
May 31, 16:00
4.15
+0.07
(+1.72%)
After-Hours: 20:00
Macrogenics Price to Book Value: 2.407 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.407 |
| May 30, 2024 | 2.502 |
| May 29, 2024 | 2.443 |
| May 28, 2024 | 2.561 |
| May 24, 2024 | 2.685 |
| May 23, 2024 | 2.732 |
| May 22, 2024 | 2.773 |
| May 21, 2024 | 2.514 |
| May 20, 2024 | 2.514 |
| May 17, 2024 | 2.576 |
| May 16, 2024 | 3.021 |
| May 15, 2024 | 2.779 |
| May 14, 2024 | 2.626 |
| May 13, 2024 | 2.584 |
| May 10, 2024 | 1.953 |
| May 09, 2024 | 8.656 |
| May 08, 2024 | 8.650 |
| May 07, 2024 | 9.470 |
| May 06, 2024 | 9.659 |
| May 03, 2024 | 9.246 |
| May 02, 2024 | 8.970 |
| May 01, 2024 | 9.164 |
| April 30, 2024 | 8.710 |
| April 29, 2024 | 8.734 |
| April 26, 2024 | 8.581 |
| Date | Value |
|---|---|
| April 25, 2024 | 8.469 |
| April 24, 2024 | 9.253 |
| April 23, 2024 | 9.565 |
| April 22, 2024 | 9.082 |
| April 19, 2024 | 9.200 |
| April 18, 2024 | 9.471 |
| April 17, 2024 | 9.488 |
| April 16, 2024 | 9.830 |
| April 15, 2024 | 9.983 |
| April 12, 2024 | 10.34 |
| April 11, 2024 | 10.91 |
| April 10, 2024 | 10.76 |
| April 09, 2024 | 10.67 |
| April 08, 2024 | 10.81 |
| April 05, 2024 | 10.75 |
| April 04, 2024 | 10.48 |
| April 03, 2024 | 8.056 |
| April 02, 2024 | 7.844 |
| April 01, 2024 | 8.262 |
| March 31, 2024 | |
| March 28, 2024 | 6.034 |
| March 27, 2024 | 6.132 |
| March 26, 2024 | 5.829 |
| March 25, 2024 | 5.907 |
| March 22, 2024 | 5.936 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7744
Minimum
Jun 16 2022
10.91
Maximum
Apr 11 2024
3.513
Average
3.005
Median
Nov 09 2022
Price to Book Value Benchmarks
| Moderna Inc | 4.262 |
| Allurion Technologies Inc | -- |
| Novavax Inc | -- |
| United Therapeutics Corp | 2.289 |
| MEI Pharma Inc | 0.3852 |
Price to Book Value Related Metrics
| PS Ratio | 6.072 |
| Price | 4.08 |
| Earnings Yield | -9.56% |
| Market Cap | 255.54M |